Table 1.
IC50 of the drugs.
Drug | BEZ235 | LY294002 | Rapamycin | Gefitinib | Cisplatin |
---|---|---|---|---|---|
Category | PI3K/mTOR inhibitor | PI3K inhibitor | mTOR inhibitor | EGFR inhibitor | Platinum chemotherapy |
FaDu * | |||||
Parental | 50 nM | 19.8 μM | 0.6 μM | 1.0 μM | 1.30 μM |
200r | 850 nM | 44.7 μM | >10 μM | 8.8 μM | 3.85 μM |
1000r | >1500 nM | 43.45 μM | >10 μM | 20 μM | 4.59 μM |
UMSCC1 * | |||||
Parental | 16.39 nM | 18.14 μM | >50 μM | 3.85 μM | 5.64 μM |
200r | >500 nM | 44.35 μM | >50 μM | >50 μM | 3.12 μM |
* The resistant cells were developed by prolonged incubation with 200 nM (200r) or 1000 nM (1000r) BEZ235.